These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 29721764

  • 1. 18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes.
    Tuominen H, Haarala A, Tikkakoski A, Kähönen M, Nikus K, Sipilä K.
    J Nucl Cardiol; 2020 Feb; 27(1):109-117. PubMed ID: 29721764
    [Abstract] [Full Text] [Related]

  • 2. FDG-PET in possible cardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events.
    Tuominen H, Haarala A, Tikkakoski A, Kähönen M, Nikus K, Sipilä K.
    J Nucl Cardiol; 2021 Feb; 28(1):199-205. PubMed ID: 30815833
    [Abstract] [Full Text] [Related]

  • 3. Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.
    Manabe O, Yoshinaga K, Ohira H, Sato T, Tsujino I, Yamada A, Oyama-Manabe N, Masuda A, Magota K, Nishimura M, Tamaki N.
    Ann Nucl Med; 2014 Aug; 28(7):656-63. PubMed ID: 24889126
    [Abstract] [Full Text] [Related]

  • 4. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
    Simonen P, Lehtonen J, Kandolin R, Schildt J, Marjasuo S, Miettinen H, Airaksinen J, Vihinen T, Tuohinen S, Haataja P, Kupari M.
    Am J Cardiol; 2015 Nov 15; 116(10):1581-5. PubMed ID: 26411357
    [Abstract] [Full Text] [Related]

  • 5. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF.
    J Am Coll Cardiol; 2014 Feb 04; 63(4):329-36. PubMed ID: 24140661
    [Abstract] [Full Text] [Related]

  • 6. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y, Grant C, Xie K, Sweiss NJ.
    Clin Nucl Med; 2017 Feb 04; 42(2):88-94. PubMed ID: 27922863
    [Abstract] [Full Text] [Related]

  • 7. 18F-FDG uptake of the right ventricle is an important predictor of histopathologic diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis.
    Omote K, Naya M, Koyanagawa K, Aikawa T, Manabe O, Nagai T, Kamiya K, Kato Y, Komoriyama H, Kuzume M, Tamaki N, Anzai T.
    J Nucl Cardiol; 2020 Dec 04; 27(6):2135-2143. PubMed ID: 30610523
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC.
    JACC Cardiovasc Imaging; 2018 Jan 04; 11(1):94-107. PubMed ID: 28624396
    [Abstract] [Full Text] [Related]

  • 11. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
    Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, Takeuchi K, Yoshikawa J.
    J Nucl Med; 2003 Jul 04; 44(7):1030-6. PubMed ID: 12843216
    [Abstract] [Full Text] [Related]

  • 12. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
    Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ.
    J Nucl Cardiol; 2017 Apr 04; 24(2):413-424. PubMed ID: 27457527
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Utility of Whole Body 18F-FDG PET-CT in Diagnosing Isolated Cardiac Sarcoidosis: The Western Australian Cardiac Sarcoid Study.
    Giudicatti L, Marangou J, Nolan D, Dembo L, Baumwol J, Dwivedi G.
    Heart Lung Circ; 2020 Jan 04; 29(1):e1-e6. PubMed ID: 31501049
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 18F-FDG-PET in Finnish patients with clinical suspicion of cardiac sarcoidosis: Female sex and history of atrioventricular block increase the prevalence of positive PET findings.
    Tuominen H, Haarala A, Tikkakoski A, Korkola P, Kähönen M, Nikus K, Sipilä K.
    J Nucl Cardiol; 2019 Apr 04; 26(2):394-400. PubMed ID: 28585031
    [Abstract] [Full Text] [Related]

  • 19. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
    Wisenberg G, Thiessen JD, Pavlovsky W, Butler J, Wilk B, Prato FS.
    J Nucl Cardiol; 2020 Dec 04; 27(6):2118-2129. PubMed ID: 30603887
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY, Carter SV, Flatley E, Ward RP, Moss JD, Appelbaum DE, Singh A, Lang RM, Tung R, Patel AR.
    Int J Cardiovasc Imaging; 2021 Apr 04; 37(4):1361-1369. PubMed ID: 33225427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.